We aimed to investigate some inexpensive, easy to perform, and noninvasive modifiable (as adiponectin and vitamin D) and nonmodifiable (as alpha-fetoprotein “AFP”) factors which may have a relation to treatment response in children with CHC. The gene discussed is AFP; the disease is cryohydrocytosis.